Pharmacogenetics of Response to Sitagliptin (PRS)
Clinical trial NCT06813014 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06813014
- Sponsor
- University of Maryland, Baltimore
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2031-11-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.